Glenmark to Pay More Than $29 Million in Multistate Generic Drug Price-Fixing Settlement
A bipartisan coalition of 49 attorneys general has secured more than $29 million from Glenmark Pharmaceuticals to resolve allegations that the company participated in a long-running scheme to inflate the prices of generic prescription drugs, New York Attorney General Letitia James announced Wednesday.
